SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001564590-20-031501
Filing Date
2020-07-01
Accepted
2020-07-01 16:16:24
Documents
77
Period of Report
2020-04-30

Document Format Files

Seq Description Document Type Size
1 10-K kalv-10k_20200430.htm 10-K 2579046
2 EX-3.4 kalv-ex34_587.htm EX-3.4 112131
3 EX-21.1 kalv-ex211_127.htm EX-21.1 6241
4 EX-23.1 kalv-ex231_11.htm EX-23.1 2123
5 EX-31.1 kalv-ex311_16.htm EX-31.1 19444
6 EX-31.2 kalv-ex312_17.htm EX-31.2 19506
7 EX-32.1 kalv-ex321_9.htm EX-32.1 8824
8 EX-32.2 kalv-ex322_10.htm EX-32.2 8757
  Complete submission text file 0001564590-20-031501.txt   7931650

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT kalv-20200430.xml EX-101.INS 1596926
10 XBRL TAXONOMY EXTENSION SCHEMA kalv-20200430.xsd EX-101.SCH 50782
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE kalv-20200430_cal.xml EX-101.CAL 70542
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE kalv-20200430_def.xml EX-101.DEF 116586
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE kalv-20200430_lab.xml EX-101.LAB 427363
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kalv-20200430_pre.xml EX-101.PRE 306062
Mailing Address 55 CAMBRIDGE PARKWAY SUITE 901E CAMBRIDGE MA 02142
Business Address 55 CAMBRIDGE PARKWAY SUITE 901E CAMBRIDGE MA 02142 (857) 999-0075
KalVista Pharmaceuticals, Inc. (Filer) CIK: 0001348911 (see all company filings)

IRS No.: 200915291 | State of Incorp.: DE | Fiscal Year End: 0430
Type: 10-K | Act: 34 | File No.: 001-36830 | Film No.: 201005539
SIC: 2834 Pharmaceutical Preparations